LATEST NEWS   Super League: Selangor FC 3-0 Melaka FC | 

There are 76 news based on search keyword " pharmaceutical "

Malaysia-US Tariff Deal In Final Stage Of Negotiations -- Tengku Zafrul

By Zufazlin Baharuddin

KUALA LUMPUR, Oct 24 (Bernama) -- Malaysia is in the final stage of tariff negotiations with the United States (US) and hopes to conclude the deal on Sunday at the 47th ASEAN Summit, said Investment, Trade and Industry Minister Tengku Datuk Seri Zafrul Abdul Aziz.

Tariffs, Rare Earths To Dominate Trump’s ASEAN Summit Visit -- Economist

By Niam Seet Wei

KUALA LUMPUR, Oct 23 (Bernama) -- Tariffs, rare earths and other critical minerals are expected to be among the key topics discussed during United States (US) President Donald Trump’s upcoming visit to the 47th ASEAN Summit here, said economist Dr Goh Lim Thye.

Curia Burlington Named Massachusetts Manufacturer Of The Year

KUALA LUMPUR, Oct 22 (Bernama) -- Curia Global Inc (Curia) announced its Burlington, Massachusetts, sterile drug product facility has been named “Manufacturer of the Year” by the Massachusetts Legislative Manufacturing Caucus.

US-Malaysia Reciprocal Agreement To Be Signed Next Week Seen As Fair -- Tengku Zafrul

KUALA LUMPUR, Oct 15 (Bernama) — The Reciprocal Trade Agreement expected to be signed between Malaysia and the United States (US) in conjunction with the 47th ASEAN Summit next week is seen as fair for both parties, taking into account their respective interests, said Investment, Trade and Industry Ministry Tengku Datuk Seri Zafrul Abdul Aziz.

EarlyHealth Buys Into Cyber Powerhouse CYB3R In Cross-Industry Expansion

KUALA LUMPUR, Oct 14 (Bernama) -- EarlyHealth Group, a global pharmaceutical services and life sciences solutions company, has acquired a 50 per cent equity stake in CYB3R Limited, one of the Gulf’s fastest-growing cybersecurity firms.

Russia Seeks Halal Meat, Dairy Export Boost To Malaysia

By Nurunnasihah Ahmad Rashid

KUALA LUMPUR, Sept 26 (Bernama) -- Russia is seeking to increase exports of halal-certified meat and dairy products to Malaysia this year as part of its strategy to deepen bilateral trade, particularly in the food and agriculture sectors.

US To Weigh Tariff Exemptions on Palm Oil, Auto And Aerospace Parts

By Nor Baizura Basri dan Nur Athirah Mohd Shaharuddin

KUALA LUMPUR, Sept 26 (Bernama) --  The United States has agreed to consider granting tariff exemptions - specifically zero tariff rates - on several commodity products not produced in the US, including palm oil and cocoa, which are expected to be finalised next month.

Saudi Healthcare Leader Calls For Global Shift: Treat Health As Investment, Not Expense

KUALA LUMPUR, Sept 25 (Bernama) -- Healthcare must be recognised as the world’s most strategic investment in security, prosperity, and resilience—not as a financial burden.

Kunak Lipids Brings Sabah's Tocotrienols To The World Stage At Vitafoods Asia

By Kenny Teng Khoon Hock

BANGKOK, Sept 20 (Bernama) -- When the doors opened at the Queen Sirikit National Convention Centre in Bangkok for Vitafoods Asia, the annual gathering of the nutraceutical world, one booth had stood out with Malaysia and Sabah’s names proudly emblazoned across its banner.

Pharmaniaga Acquires Penang Property For RM30 Mln

KUALA LUMPUR, Sept 19 (Bernama) -- Pharmaniaga Bhd's wholly-owned unit, Pharmaniaga Logistics Sdn Bhd has entered into a sale and purchase agreement (SPA) with N H Development Sdn Bhd to acquire a property in Seberang Perai Selatan, Penang for RM30 million.

Malaysia Aims To Diversify Supply Chains In Semiconductor Sector -- Liew

KUALA LUMPUR, Sept 4 (Bernama) -- Malaysia aims to diversify supply chains in the semiconductor sector to ensure that foreign and local investments remain strong and resilient, said Deputy Investment, Trade and Industry Minister Liew Chin Tong.

MBSB IB Maintains Positive Call On Insurance Sector Despite Healthcare Inflation

KUALA LUMPUR, Aug 15 (Bernama) -- MBSB Investment Bank (MBSB IB) has maintained its “positive” recommendation on the insurance sector, citing attractive valuations and high dividend yields despite persistent healthcare inflation and delays in healthcare cost-control reforms.